Massive cancer vaccination starts in Aus schools
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2013
Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers a...Read more
Patrys gets approval for myeloma trials in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2012
Singapore: Patrys has received approval to commence its planned phase I/IIa multiple myeloma trial with lead anti-canc...Read more
AtCor revenue up by 41 percent in FY 2013
Australia | Company results | By BioSpectrum Bureau | 4 Comment | 02 Sep, 2013
Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central aortic blood pressur...Read more
Patrys cancer drug gives hope to patients
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...Read more
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2015
Singapore: The bioscience industry in the major markets of Asia-Pacific region, excluding Japan and comprising Australia...Read more
BSA-CMR Survey: New CRO players emerge in APAC
Australia | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
ImmusanT starts trials of celiac disease vaccine, Nexvax2
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012
Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first thera...Read more
Queensland marks 15% less HIV cases in 2013
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2013
Singapore: Ministerial Advisory Committee on HIV/AIDS (MAC) in Australia has achieved 15 percent reduction in HIV notifi...Read more
Alchemia gets US patent for oncology platform technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to ...Read more
Elsevier: Prana drug among 'Top 10 CNS Projects'
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...Read more
Aussies commit $652 mn for medical research
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Oct, 2012
Singapore: Australia Minister for Health, Ms Tanya Plibersek, announced that $652 million will be provided for 1,141 gra...Read more
BioDiem partners with VIVALIS for vaccine development
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2012
Singapore: Australian vaccine development company BioDiem announced that it has begun research collaboration with France...Read more
Atcor's SphygmoCor XCEL gets Mexican nod
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system which measures central aor...Read more
Avexa to invest in mining to fund drug development
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Nov, 2012
Singapore: How far will a drug company go to fund drug discovery and development? Melborne-based biotechnology company A...Read more
Clinuvel gets positive results in Scenesse trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...Read more
BioPharma Asia: Dr Deborah Rathjen wins Life Science Woman Executive of the Year award
Australia | Influencers | By BioSpectrum Bureau | 3 Comment | 17 Mar, 2014
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...Read more
Hyaluronic acid properties to enhance drug delivery
Australia | News | By Nandita Singh | 0 Comment | 14 Mar, 2012
A company that has been leveraging on drug delivery products is Alchemia. Its HyACT technology uses hyaluronic acid's (H...Read more
Pfizer to shut plant in Australia, slash 140 jobs
Australia | News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2013
Singapore: Pfizer will make a phased exit of its West Ryde plant in Australia, which produces tablets and capsules for b...Read more